Silymarin may inhibit cytochrome P450 2C9 and CYP450 3A4; but no effect on pharmacokinetics of indinavir in human studies. Silymarin may decrease blood glucose in patients with cirrhosis and diabetes.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education